November 2019

In a month where we say 'Happy 150th birthday' to Nature. Our November issue includes partnering companies focused on infectious diseases, specifically viral diseases such as influenza among others.

The editorial features cover the biopharmas targeting common viral denominators to battle flu and the art of closing a biopharma deal.